Correlation between thrombocytopenia and adverse outcomes in patients with atrial fibrillation: a systematic review and meta-analysis
2024

Thrombocytopenia and Outcomes in Atrial Fibrillation Patients

Sample size: 73824 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ding Qiuhua, Xu Wenlin, Chen Yaoyao, Chang Sijie, Zhang Jinhua

Primary Institution: Fujian Maternity and Child Health Hospital, Fujian Medical University, Fuzhou, China

Hypothesis

What is the impact of thrombocytopenia on adverse outcomes in patients with atrial fibrillation?

Conclusion

Thrombocytopenia is linked to a lower risk of ischemic stroke/systemic embolism but a higher risk of major bleeding and all-cause mortality in patients with atrial fibrillation.

Supporting Evidence

  • Thrombocytopenia is associated with a lower risk of ischemic stroke/systemic embolism.
  • Thrombocytopenia significantly increases the risk of major bleeding.
  • Thrombocytopenia is linked to a higher risk of all-cause mortality.

Takeaway

Having low platelets can help prevent some strokes in heart patients, but it can also make them bleed more and increase their chances of dying.

Methodology

A systematic review and meta-analysis of studies on atrial fibrillation patients with thrombocytopenia, using data from PubMed and Web of Science.

Potential Biases

Potential bias due to the inclusion of studies from different regions with varying baseline characteristics.

Limitations

The number of studies and patients included were not enough, leading to a lack of confidence in some outcome indicators.

Participant Demographics

Average age: 72.67 years; 57.3% male.

Statistical Information

P-Value

P<0.01

Confidence Interval

(0.69, 0.91)

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.3389/fcvm.2024.1383470

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication